← Back
$LGND All transactions

LIGAND PHARMACEUTICALS INC

▼ SELL

$ Value

$104K

Shares

1,000

Price

$104

Filed

Jun 2

Insider

Name

Reardon Andrew

Title

CLO & Secretary

CIK

0001950232

Roles

Officer

Transaction Details

Transaction Date

2025-05-15

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

32,903

Footnotes

Represents shares withheld by the Issuer in payment of the tax liability arising in connection with the settlement of restricted stock units. | The total includes 17 shares acquired on December 31, 2024, through the Issuer's Employee Stock Purchase Plan.

Filing Info

Accession No.

0002001011-25-000037

Form Type

4

Issuer CIK

0000886163

Reardon Andrew's History

Date Ticker Type Value
2026-04-01 LGND M $261K
2026-04-01 LGND $91K
2026-04-01 LGND $260K
2026-04-01 LGND $249K
2026-04-01 LGND $141K
2026-04-01 LGND $196K
2026-04-01 LGND $69K
2026-04-01 LGND M $0
2026-03-02 LGND A $0
2026-03-02 LGND A $0

Other Insiders at LGND (90d)

Insider Bought Sold Last
LAMATTINA JOHN L $434K 2026-03-06
KOZARICH JOHN W $94K 2026-04-01
Davis Todd C
Chief Executive Officer
2026-03-02
Sabba Stephen L $208K 2026-03-23
Espinoza Octavio
Chief Financial Officer
2026-03-02
Reardon Andrew
CLO & Secretary
$1.0M 2026-04-01